Sintrom
Sintrom is a brand name for acenocoumarol, an oral anticoagulant that functions as a vitamin K antagonist. It is used to prevent and treat thromboembolic events such as deep vein thrombosis (DVT), pulmonary embolism (PE), and strokes in patients with atrial fibrillation or mechanical heart valves. By inhibiting vitamin K recycling, Sintrom reduces the synthesis of clotting factors, thereby diminishing the blood's ability to form harmful clots.
The mechanism by which Sintrom works centers on blocking the enzyme vitamin K epoxide reductase. This enzyme is pivotal in regenerating active vitamin K, which the liver needs to produce clotting factors II, VII, IX, and X. When these factors are deficient, the coagulation process slows, reducing the risk that blood clots will develop or grow larger.
Managing therapy with Sintrom requires careful and regular monitoring using a test known as the prothrombin time (PT), reported as the International Normalized Ratio (INR). Because individual responses to acenocoumarol can vary widely, healthcare providers tailor the dose to achieve a target INR range depending on the condition being treated. Frequent INR checks are necessary, especially when starting therapy or making dose adjustments, to ensure the balance between preventing clots and avoiding excessive bleeding.
Side effects of Sintrom primarily relate to its anticoagulant action. Patients are at increased risk of bleeding episodes, which can range from minor bruising or nosebleeds to more severe complications such as gastrointestinal bleeding or hemorrhagic stroke. Therefore, any unusual bleeding should be reported immediately. Furthermore, fluctuations in diet—particularly in vitamin K intake—can affect INR levels, so patients should maintain a consistent dietary pattern.
Drug interactions are another significant consideration, as many medications (prescription, over-the-counter, and herbal supplements) can potentiate or diminish acenocoumarol's effects. Consequently, patients on Sintrom are advised to keep their healthcare providers informed about all medications and supplements they take. With diligent monitoring, strict adherence to dosing schedules, and awareness of potential interactions, Sintrom can be a potent and safe tool for preventing thromboembolic events in at-risk individuals.
NOTE: The above information is for marketing purposes only and is not to be construed as medical advice. Seek advice for medications from a qualified physician.
The mechanism by which Sintrom works centers on blocking the enzyme vitamin K epoxide reductase. This enzyme is pivotal in regenerating active vitamin K, which the liver needs to produce clotting factors II, VII, IX, and X. When these factors are deficient, the coagulation process slows, reducing the risk that blood clots will develop or grow larger.
Managing therapy with Sintrom requires careful and regular monitoring using a test known as the prothrombin time (PT), reported as the International Normalized Ratio (INR). Because individual responses to acenocoumarol can vary widely, healthcare providers tailor the dose to achieve a target INR range depending on the condition being treated. Frequent INR checks are necessary, especially when starting therapy or making dose adjustments, to ensure the balance between preventing clots and avoiding excessive bleeding.
Side effects of Sintrom primarily relate to its anticoagulant action. Patients are at increased risk of bleeding episodes, which can range from minor bruising or nosebleeds to more severe complications such as gastrointestinal bleeding or hemorrhagic stroke. Therefore, any unusual bleeding should be reported immediately. Furthermore, fluctuations in diet—particularly in vitamin K intake—can affect INR levels, so patients should maintain a consistent dietary pattern.
Drug interactions are another significant consideration, as many medications (prescription, over-the-counter, and herbal supplements) can potentiate or diminish acenocoumarol's effects. Consequently, patients on Sintrom are advised to keep their healthcare providers informed about all medications and supplements they take. With diligent monitoring, strict adherence to dosing schedules, and awareness of potential interactions, Sintrom can be a potent and safe tool for preventing thromboembolic events in at-risk individuals.
NOTE: The above information is for marketing purposes only and is not to be construed as medical advice. Seek advice for medications from a qualified physician.
We are not currently selling this medicine.